Junshi Biosciences is a leading pharmaceutical company operating in discovering and developing monoclonal antibody drugs in China. Founder Jun Xiong has strong spirit of innovation; core team has established the leading position in the field of tumor immunity research and development.

The Company has produced a robust pipeline of monoclonal antibody drugs which cover tumor, cardiovascular disease, osteoporosis, and many other fields.